Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
VisionCare, Inc.
Every 6 months, manifest refraction, visual acuity, intraocular pressure, slit lamp examination, endothelial cell density, device failures, complications and adverse events will be assessed.
Age
55–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have participated in the IMT-002 trial.
Patients must be able to understand and comply with the requirements of the clinical study, and be able to abide by the requirements and restrictions of the study.
Patients must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form.
You may not be if
Patients who have not participated in the IMT-002 trial.
Clareo Health | A Long-Term Monitoring Study of the IMT-002 Patients
